Tenax Therapeutics (TENX) FCF Margin (2010 - 2015)

Tenax Therapeutics' FCF Margin history runs 5 years deep, the most recent figure standing at 6810.14% for Q2 2015.

• In Q2 2015, FCF Margin changed N/A year-over-year to 6810.14%; the TTM figure through Jun 2016 stood at 41810.97% (down 4146380.0% YoY), while the FY2015 annual figure was 19788.64%, down 1626333.0% from the prior year.
• FCF Margin came in at 6810.14% for Q2 2015 at Tenax Therapeutics, down from 794.57% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 219.27% in Q4 2012 to a low of 9737.26% in Q1 2011.
• A 4-year average of 3329.82% and a median of 1582.78% in 2012 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin jumped 817908 bps in 2012 and surged 78820 bps in 2013, its largest moves.
• Tenax Therapeutics' FCF Margin stood at 2667.66% in 2011, then surged by 92 bps to 219.27% in 2012, then slumped by 262 bps to 794.57% in 2013, then plunged by 757 bps to 6810.14% in 2015.
• According to Business Quant data, FCF Margin over the past three periods registered 6810.14%, 794.57%, and 335.32% for Q2 2015, Q2 2013, and Q1 2013 respectively.

Peer Comparison